RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK)
Germany · Delayed Price · Currency is EUR 13.10
+0.30 (2.34%)
Jul 29, 2026, 3:02 PM CET
ETR:RHK Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,861 | 1,705 | 1,596 | 1,736 | 1,666 | 1,600 | |
Revenue Growth | 5.70% | 6.84% | -8.11% | 4.22% | 4.11% | 2.83% |
Cost of Revenue | 1,717 | 1,694 | 1,584 | 1,463 | 1,396 | 1,352 |
Gross Profit | 144.32 | 10.65 | 11.63 | 273.58 | 269.78 | 248.68 |
Depreciation & Amortization Expenses | 65.14 | 65.01 | 62.62 | 65.49 | 69.53 | 70.64 |
Other Operating Expenses | 85.05 | - | - | 167.69 | 164.13 | 147.52 |
Total Operating Expenses | 150.19 | 65.01 | 62.62 | 233.18 | 233.67 | 218.16 |
Operating Income | -5.87 | 40.94 | 48.15 | 40.4 | 36.11 | 30.52 |
Interest Income | 6.81 | 7.34 | 11.18 | 10.54 | 1.37 | 0.58 |
Interest Expense | -3.07 | -3.21 | -3.44 | -3.69 | -4.07 | -3.19 |
Other Non-Operating Income (Expense) | -0.09 | 94.89 | 99.74 | 0.48 | 0.22 | -0.55 |
Total Non-Operating Income (Expense) | 3.64 | 99.02 | 107.48 | 7.33 | -2.48 | -3.16 |
Pretax Income | 52.03 | 44.95 | 56.2 | 47.73 | 33.63 | 27.36 |
Provision for Income Taxes | 9.95 | 8.67 | 11 | 7.56 | 6.69 | -2.87 |
Net Income | 42.08 | 36.28 | 45.21 | 40.17 | 26.94 | 30.23 |
Minority Interest in Earnings | 2.03 | 1.81 | 1.86 | 1.46 | 1.8 | 1.93 |
Net Income to Common | 40.05 | 34.47 | 43.35 | 38.71 | 25.14 | 28.3 |
Net Income Growth | 0.92% | -20.48% | 11.98% | 53.96% | -11.14% | 1850.03% |
Shares Outstanding (Basic) | 67 | 67 | 67 | 67 | 67 | 67 |
Shares Outstanding (Diluted) | 67 | 67 | 67 | 67 | 67 | 67 |
Shares Change | -0.27% | - | - | - | - | - |
EPS (Basic) | 0.60 | 0.52 | 0.65 | 0.58 | 0.38 | 0.42 |
EPS (Diluted) | 0.60 | 0.52 | 0.65 | 0.58 | 0.38 | 0.42 |
EPS Growth | 0% | -20.00% | 12.07% | 52.63% | -9.52% | 2000.00% |
Free Cash Flow | - | -41.9 | 57.2 | 46.2 | 2.1 | 19.7 |
Free Cash Flow Growth | - | - | 23.81% | 2100.00% | -89.34% | 20.86% |
Free Cash Flow Per Share | - | -0.63 | 0.85 | 0.69 | 0.03 | 0.29 |
Dividends Per Share | 0.200 | 0.200 | 0.100 | - | 0.150 | - |
Dividend Growth | 100.00% | 100.00% | - | - | - | - |
Gross Margin | 7.75% | 0.62% | 0.73% | 15.76% | 16.19% | 15.54% |
Operating Margin | -0.32% | 2.40% | 3.02% | 2.33% | 2.17% | 1.91% |
Profit Margin | 2.26% | 2.13% | 2.83% | 2.31% | 1.62% | 1.89% |
FCF Margin | - | -2.46% | 3.58% | 2.66% | 0.13% | 1.23% |
EBITDA | -5.87 | 105.84 | 110.75 | 106 | 105.71 | 100.72 |
EBITDA Margin | -0.32% | 6.21% | 6.94% | 6.10% | 6.34% | 6.29% |
EBIT | -5.87 | 40.94 | 48.15 | 40.4 | 36.11 | 30.52 |
EBIT Margin | -0.32% | 2.40% | 3.02% | 2.33% | 2.17% | 1.91% |
Effective Tax Rate | 19.12% | 19.28% | 19.57% | 15.84% | 19.89% | -10.47% |